Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “SION”

1,496 pharma patents match "SION" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,496
Index total 30,257
Page 39 / 63

Quick answer

This filtered view shows 1,496 pharmaceutical patents matching "SION" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,496 results for “SION” · 30,257 patents in full index Clear search

  1. US 9162980

    Anti-depression compounds

    The Board of Regents of the University of Texas System · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted

  2. US 9149450

    Ischemia/reperfusion protection compositions and methods of using

    Regents of the University of Minnesota · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted

  3. US 9150847

    Methods and compositions for regulation of transgene expression

    Sangamo Biosciences, Inc. · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted

  4. US 9149501

    Methods of treating depression and other related diseases

    Northwestern University · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted

  5. US 9139634

    Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activities

    The Regents of the University of California · Granted Sep 22, 2015 · Expires Sep 17, 2035

    granted

  6. US 9133454

    Method and medicament for inhibiting the expression of a given gene

    Alnylam Pharmaceuticals, Inc. · Granted Sep 15, 2015 · Expires Sep 10, 2035

    granted

  7. US 9133461

    Compositions and methods for inhibiting expression of the ALAS1 gene

    Alnylam Pharmaceuticals, Inc. · Granted Sep 15, 2015 · Expires Sep 10, 2035

    granted

  8. US 9115205

    Plasmodium falciparum circumsporozoite vaccine gene optimization for soluble protein expression

    The United States of America as represented by the Secretary of the Army · Granted Aug 25, 2015 · Expires Aug 20, 2035

    granted

  9. US 9101643

    Lipid formulated compositions and methods for inhibiting expression of transthyretin (TTR)

    Alnylam Pharmaceuticals, Inc. · Granted Aug 11, 2015 · Expires Aug 6, 2035

    granted

  10. US 9095562

    Methods and compositions for optimized expansion and implantation of mesenchymal stem cells

    REGENERATIVE SCIENCES, LLC · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  11. FR 3016881

    TRAITEMENT DES DEGENERESCENCES ET DES LESIONS PHOTO-INDUITES DE LA RETINE

    BIOCODEX [FR] · Granted Jul 31, 2015 · Expires Jul 26, 2035

    granted

  12. US 9090895

    Compositions and methods for inhibiting expression of the HAMP gene

    Alnylam Pharmaceuticals, Inc. · Granted Jul 28, 2015 · Expires Jul 23, 2035

    granted

  13. US 9089506

    Stable, non-irritating topical formulations of hydroquinone

    Precision Dermatology, Inc. · Granted Jul 28, 2015 · Expires Jul 23, 2035

    granted

  14. US 9085598

    Compounds targeting the cell invasion protein complex, their pharmaceutical compositions and methods of use thereof

    OCEAN UNIVERSITY OF CHINA · Granted Jul 21, 2015 · Expires Jul 16, 2035

    granted

  15. US 9074212

    RNAi inhibition of alpha-ENaC expression

    Arrowhead Research Corporation · Granted Jul 7, 2015 · Expires Jul 2, 2035

    granted

  16. US 9074213

    Compositions and methods for inhibiting expression of a target gene

    Alnylam Pharmaceuticals, Inc. · Granted Jul 7, 2015 · Expires Jul 2, 2035

    granted

  17. US 9068014

    Colon and pancreas cancer peptidomimetics

    PRECISION BIOLOGICS, INC. · Granted Jun 30, 2015 · Expires Jun 25, 2035

    granted

  18. CA 2934118

    PROPIONATE DE CORTEXOLONE-17' DESTINE A ETRE UTILISE DANS LE TRAITEMENT DE LESIONS CUTANEES ET/OU DE TROUBLES DE LA PEAU ATROPHIQUE

    CASSIOPEA S P A [IT] · Granted Jun 25, 2015 · Expires Jun 20, 2035

    granted

  19. US 9062288

    Therapeutic methods using adipose tissue-derived cell suspensions comprising adipocytes

    Regeneus LTD · Granted Jun 23, 2015 · Expires Jun 18, 2035

    granted

  20. US 9062310

    Compositions and methods for inhibiting expression of factor VII gene

    Alnylam Pharmaceuticals, Inc. · Granted Jun 23, 2015 · Expires Jun 18, 2035

    granted

  21. US 9057069

    Compositions and methods for inhibiting expression of Eg5 gene

    Alnylam Pharmaceuticals, Inc. · Granted Jun 16, 2015 · Expires Jun 11, 2035

    granted

  22. US 9056129

    Precision-guided nanoparticle systems for drug delivery

    Northwestern University · Granted Jun 16, 2015 · Expires Jun 11, 2035

    granted

  23. US 9050298

    Method of treating ischemia/reperfusion injuries to a heart with netrin-1

    The Regents of the University of California · Granted Jun 9, 2015 · Expires Jun 4, 2035

    granted

  24. US 9051550

    Cellular seeding and co-culture of a three dimensional fibroblast construct

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Jun 9, 2015 · Expires Jun 4, 2035

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.